View by Specialty

Headline News

View more

Proposed biosimilar shows equivalence to golimumab in rheumatoid arthritis

April 25, 2024
1 min read
Save

Proposed biosimilar shows equivalence to golimumab in rheumatoid arthritis

Proposed biosimilar shows equivalence to golimumab in rheumatoid arthritis

A biosimilar for golimumab has demonstrated therapeutic equivalence in rheumatoid arthritis, with no clinically meaningful safety differences, according to a press release from the manufacturer.

View more Headline News
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails

Resources

View more

Biosimilars in the United States: Current Status and Future Implications

Healio Special Report: Health Care and Politics

This collection of articles includes the latest news on health care laws and policies in the United States and their impact on patient care.

View resource

Race and Medicine

Racially diverse paper dolls with stethoscope

This collection seeks to bring together research on racial disparities across our specialties along with perspectives from physicians from various racial backgrounds.

View resource
View more Resources
View more Meeting News
View meeting calendar

Podcasts

View more
Rheumatology, Practice Management, Psoriatic Arthritis 22005361_Healio Minute_OG_1200x630
Rheumatology Healio Rheuminations
View more Podcasts

Blogs & Columns

View more
Leonard Calabrese, DO

Editorial

with Leonard H. Calabrese, DO
View more Blogs & Columns